Talius Group (ASX:TAL) has been selected by the Brisbane Economic Development Agency to participate in the MedTech global accelerator program for 2026, according to a Monday filing with the Australian bourse.
The program supports the launch of a funding campaign and fast-track connections with funders, licensing and distribution partners, the filing said.
Shares of the company rose 3% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.